NYSE: ASH

ASHLAND INC.

CIK 0001674862 · SIC 5160 · Chemicals & Allied Products

Mid Revenue $1.9B Assets $4.5B as of Nov 22, 2026

Ashland Inc. is a global additives and specialty ingredients company with a conscious and proactive mindset for sustainability. Our common stock is listed on the New York Stock Exchange (“NYSE”) under the ticker symbol “ASH”. The terms “Ashland,” the “Company,” “we” and “our” used herein refer to… About this business →

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.

10-K Filed Nov 20, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

8-K Filed Nov 3, 2026 · Period ending Nov 3, 2026

Summary not yet generated.

Partner

Trade ASH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Sep 25, 2026 · Period ending Sep 24, 2026

Summary not yet generated.

8-K Filed Jul 31, 2026 · Period ending Jul 30, 2026

Summary not yet generated.

10-Q Filed Jul 29, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

10-Q Filed Apr 29, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed Nov 20, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

Latest financial statements

From 10-K filed Nov 20, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Statements of Consolidated Comprehensive Income (Loss)

(In millions except per share data)

Description 2026 2025 2024
Sales Note P 1,863 1,824 2,113
Cost of sales Note Q 1,262 1,275 1,495
Gross profit 601 549 618
Selling, general and administrative expense Note Q 377 344 404
Research and development expense Note Q 55 54 55
Intangibles amortization expense Note G and Note Q 60 63 76
Equity and other income Note Q 4 4 6
Goodwill impairment Note G and Note Q — 706 —
Loss on divestitures, net Note B and Note Q (8) (161) (115)
Operating income (loss) 105 (775) (26)
Net interest and other expense (income) Note H 40 33 (24)
Other net periodic benefit (income) loss Note L (4) 1 22
Income (loss) from continuing operations before income taxes 69 (809) (24)
Income tax expense (benefit) Note K 44 13 (223)
Income (loss) from continuing operations 25 (822) 199
Loss from discontinued operations, net of income taxes Note C (21) (23) (30)
Net income (loss) 4 (845) 169
PER SHARE DATA - NOTE A
Basic earnings (loss) per share
Income (loss) from continuing operations 0.55 (17.74) 3.99
Loss from discontinued operations (0.46) (0.49) (0.59)
Net income (loss) 0.09 (18.23) 3.40
Diluted earnings (loss) per share
Income (loss) from continuing operations 0.55 (17.74) 3.95
Loss from discontinued operations (0.46) (0.49) (0.59)
Net income (loss) 0.09 (18.23) 3.36
COMPREHENSIVE INCOME (LOSS)
Net income (loss) 4 (845) 169
Other comprehensive income, net of tax
Unrealized translation gain 1 45 54
Unrealized gain on commodity hedges 2 2 1
Other comprehensive income Note N 3 47 55
Comprehensive income (loss) 7 (798) 224

Consolidated Balance Sheets

(In millions)

Description 2026 2025
ASSETS
Current assets
Cash and cash equivalents 480 215
Accounts receivable, net(a) Notes A and H 266 242
Inventories Note A 482 568
Other assets 108 180
Total current assets 1,336 1,205
Noncurrent assets
Property, plant and equipment - Note F
Cost 3,304 3,355
Accumulated depreciation 2,170 2,154
Net property, plant and equipment 1,134 1,201
Goodwill Note G 698 705
Intangibles, net Note G 498 563
Operating lease assets, net Note J 99 103
Restricted investments Note E 248 297
Asbestos insurance receivable, net(b) Notes A and M 137 127
Deferred income taxes Note K 138 157
Other assets Note I 239 253
Total noncurrent assets 3,191 3,406
Total assets 4,527 4,611
LIABILITIES AND EQUITY
Current liabilities
Trade and other payables 210 189
Accrued expenses and other liabilities 220 213
Current portion of long-term debt Note H 4 —
Current operating lease obligations Note J 18 21
Total current liabilities 452 423
Noncurrent liabilities
Long-term debt Note H 1,367 1,384
Asbestos litigation reserves Note M 385 389
Deferred income taxes Note K 24 31
Employee benefit obligations Note L 77 96
Operating lease obligations Note J 83 85
Other liabilities Note I 291 299
Total noncurrent liabilities 2,227 2,284
Commitments and contingencies - Notes J and M
Equity - Notes N and O
Common stock, par value $.01 per share, 200 million shares authorized 1 1
Issued 46 million shares in both 2026 and 2025
Paid-in capital 20 6
Retained earnings 2,225 2,298
Accumulated other comprehensive loss (398) (401)
Total equity 1,848 1,904
Total liabilities and equity 4,527 4,611

Statements of Consolidated Cash Flows

(In millions)

Description Years ended September 30, 2026 Years ended September 30, 2025 Years ended September 30, 2024
CASH FLOWS PROVIDED (USED) BY OPERATING ACTIVITIES FROM CONTINUING OPERATIONS
Net income (loss) 4 (845) 169
Loss from discontinued operations, net of income taxes 21 23 30
Adjustments to reconcile income (loss) from continuing operations to cash flows from operating activities
Depreciation and amortization 185 237 274
Original issue discount and debt issuance cost amortization 8 7 6
Deferred income taxes 7 73 (302)
Gain from sales of property and equipment (5) (16) —
Equity income from affiliates (1) — —
Stock based compensation expense Note O 18 14 15
Loss from excess tax deduction on stock based compensation (1) (3) —
Income from restricted investments (21) (33) (74)
Loss on divestitures, net Note B 13 177 107
Goodwill impairment — 706 —
Asset impairments 18 — 11
Pension contributions (12) (12) (15)
(Gain) loss on pension and other postretirement plan remeasurements (7) (3) 14
Change in operating assets and liabilities(a) 158 (191) 227
Total cash flows provided by operating activities from continuing operations 385 134 462
CASH FLOWS PROVIDED (USED) BY INVESTING ACTIVITIES FROM CONTINUING OPERATIONS
Additions to property, plant and equipment (88) (98) (137)
Proceeds from disposal of property, plant and equipment 6 16 —
Proceeds from sale or restructuring of operations 2 16 26
Proceeds from settlement of company-owned life insurance contracts 27 12 1
Company-owned life insurance payments (4) (5) (5)
Funds restricted for specific transactions (9) (8) (5)
Reimbursement from restricted investments 74 62 79
Proceeds from sale of securities 71 56 53
Purchase of securities (71) (54) (53)
Other investing cash flows — — (10)
Total cash flows provided (used) by investing activities from continuing operations 8 (3) (51)
CASH FLOWS USED BY FINANCING ACTIVITIES FROM CONTINUING OPERATIONS
Repayment of short-term debt — — (16)
Repurchase of common stock — (100) (380)
Debt issuance costs (2) — —
Cash dividends paid (76) (76) (78)
Stock based compensation employee withholding taxes paid in cash (3) (3) (5)
Total cash flows used by financing activities from continuing operations (81) (179) (479)
CASH PROVIDED (USED) BY CONTINUING OPERATIONS 312 (48) (68)
Cash used by discontinued operations
Operating cash flows (46) (40) (51)
Total cash used by discontinued operations (46) (40) (51)
Effect of currency exchange rate changes on cash and cash equivalents (1) 3 2
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 265 (85) (117)
CASH AND CASH EQUIVALENTS BEGINNING OF YEAR 215 300 417
CASH AND CASH EQUIVALENTS END OF YEAR 480 215 300
CHANGES IN ASSETS AND LIABILITIES(a)
Accounts receivable, net (25) (3) 96
Inventories 87 (28) 79
Trade and other payables 26 (63) 56
Other assets and liabilities 70 (97) (4)
CHANGE IN OPERATING ASSETS AND LIABILITIES 158 (191) 227
SUPPLEMENTAL DISCLOSURES
Interest paid 53 54 52
Income taxes (received) paid, net (including discontinued operations)(b) (58) 33 53

Amounts as printed on the EDGAR/iXBRL face — (In millions except per share data); (In millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

About ASHLAND INC.

Source: Item 1 (Business) from the 10-K filed November 20, 2026. Description as filed by the company with the SEC.

ITEM 1. BUSINESS

GENERAL

Ashland Inc. is a global additives and specialty ingredients company with a conscious and proactive mindset for sustainability. Our common stock is listed on the New York Stock Exchange (“NYSE”) under the ticker symbol “ASH”. The terms “Ashland,” the “Company,” “we” and “our” used herein refer to Ashland Inc., a Delaware corporation, and its predecessors, and its consolidated subsidiaries, except where the context indicates otherwise.

The Company serves customers in a wide range of consumer and industrial markets including, architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. With approximately 2,800 employees worldwide, Ashland serves customers in more than 100 countries.

Ashland’s reportable operating segments ("reportable segments") include: Life Sciences, Personal Care, Specialty Additives and Intermediates. Unallocated and other includes corporate governance activities and certain legacy matters.

Life Sciences is composed of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films (formerly known as advanced materials). Pharmaceutical solutions include controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers and tablet binders, and formulation-enabling technologies used in oral, injectable, biologic, and advanced therapeutic drug formulations. The portfolio also includes bioprocessing chemicals that support the development and manufacture of biologics, vaccines, and other therapeutic products. Nutrition solutions include thickeners, stabilizers, emulsifiers and additives for enhancing mouthfeel, controlling moisture migration, reducing oil uptake and binding structured foods. Agricultural chemicals solutions include specialty polymers, bio-based technologies, dispersants, and formulation aids that improve the performance, stability, delivery, and application of crop protection products, biologicals, seed treatments, and other agricultural formulations. Customers include pharmaceutical, food and beverage manufacturers, hospitals and radiologists. The nutraceuticals business was sold in August 2024.

Read full description ↓

Personal Care is composed of biofunctionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. These businesses have a broad range of natural, nature-derived, biodegradable, and high-performance ingredients for customer-driven solutions to help protect, renew, moisturize and revitalize skin and hair, and provide solutions for toothpastes, mouth washes and rinses, denture cleaning and care for teeth. Personal Care supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers for household, industrial and institutional cleaning products. Customers include formulators at large multinational branded consumer products companies and smaller, independent boutique companies. The Avoca business was sold in March 2025.

Specialty Additives is composed of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. Solutions include coatings additives for architectural paints, finishes and lacquers, cement- and gypsum-based dry mortars, ready-mixed joint compounds, synthetic plasters for commercial and residential construction, and specialty materials for industrial

3

applications. Products include rheology modifiers (cellulosic and associative thickeners), foam control agents, surfactants and wetting agents, pH neutralizers and environmental filters, ingredients that aid the manufacturing process of ceramic capacitors, advanced ceramics used in catalytic converters, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals and alloys for welding. Products help improve desired functional outcomes through rheology modification and control, water retention, workability, adhesive strength, binding power, film formation, deposition and suspension and emulsification. Customers include, but are not limited to, global paint manufacturers, electronics and automotive manufacturers, textile mills, the construction industry and welders.

Intermediates is composed of the production of 1,4 butanediol ("BDO") and related derivatives, including n-methylpyrrolidone. These products are used as chemical intermediates in the production of engineering polymers and polyurethanes, and as specialty process solvents in a wide array of applications including electronics, agriculture, pharmaceuticals, water filtration membranes and more. BDO is also supplied to Life Sciences, Personal Care, and Specialty Additives reportable segments for use as a raw material.

Unallocated and Other generally includes items such as certain significant company-wide restructuring activities, corporate governance costs and legacy costs or activities that relate to divested businesses that are no longer operated by Ashland.

Available Information -

Our principal executive offices are located at 8145 Blazer Drive, Wilmington, Delaware 19808.

On the Investor Relations section of our website, www.ashland.com, you may obtain additional information about us, free of charge, including:

•
our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, amendments to such reports, and other documents as soon as reasonably practicable after we file them with or furnish them to the Securities and Exchange Commission (“SEC”);

•
beneficial ownership reports filed by officers, directors, and principal security holders under Section 16(a) of the Securities Exchange Act of 1934, as amended (or the “Exchange Act”); and

•
corporate governance information that includes our:

o
corporate governance guidelines,

o
audit committee charter,

o
compensation committee charter,

o
sustainability and productivity committee charter,

o
governance and nominating committee charter, and

o
director independence standards.

We also provide printed copies of any of these documents to any stockholder free of charge upon request. The SEC also maintains a website (www.sec.gov) that contains reports, proxy and information statements and other information that is filed electronically with the SEC.

LIFE SCIENCES

Life Sciences is a leading supplier of excipients, formulation technologies, and tablet coating systems serving the pharmaceutical, nutrition industries, agricultural chemicals, and diagnostic films.

4

Its pharmaceutical portfolio includes a comprehensive range of polymers and functional excipients used as tablet binders, super disintegrants, sustained-release agents and drug solubilizers, as well as coating systems for immediate, delayed, and sustained-release applications. The portfolio also includes excipients and formulation-enabling technologies used in injectable, biologic, and advanced therapeutic drug formulations to improve solubility, bioavailability, stability, manufacturability, and product performance. In addition, the Life Sciences portfolio provides specialty materials used in bioprocessing applications supporting the development and manufacture of biologics, vaccines, and other therapeutic products. Core pharmaceutical products include cellulosics and vinyl pyrrolidone polymers which are used primarily in oral solid dosage drug formulations.

Its nutrition portfolio provides functional benefits in areas such as thickening, texture control, thermal gelation, structure enhancement, water binding, clarification, and stabilization. Its core products include cellulose gums and vinyl pyrrolidone polymers which are used in a wide range of offerings for bakery, beverage, dairy, desserts, meat products, pet food, prepared foods, sauces and savory products.

Its agricultural chemicals portfolio provides formulation technologies and specialty ingredients that enhance the performance, stability, and delivery of crop protection products, seed treatments, biologicals, and other agricultural formulations. Core products include functional polymers, bio-based technologies, and formulation aids used to improve dispersion, suspension, adhesion, compatibility, and application performance.

Life Science markets and distributes its products across the Americas, Europe, the Middle East, Africa and Asia Pacific. It serves its end markets through 10 manufacturing facilities and 10 laboratory facilities, which may share sites and therefore do not necessarily represent 20 distinct locations. Its US facilities are located in Texas City, Texas; Calvert City, Kentucky; Columbus, Ohio; Bridgewater, New Jersey, and Wilmington, Delaware; and internationally in Brazil; Belgium, China; France, Germany; India; Ireland; Mexico; Netherlands, Thailand; and Turkey.

For the year ended September 30, 2026, the following Life Sciences product categories were 10% or greater of Ashland’s total consolidated sales:

Product

% of Life Sciences sales

% of Ashland total consolidated sales

Cellulosics

47%

40%

Polyvinylpyrrolidones ("PVP")

39%

24%

PERSONAL CARE

The Personal Care portfolio of oral care products delivers active ingredients in toothpaste and mouthwashes; provides bioadhesive functionality for dentures; delivers flavor, texture and other functional properties; and provides product binding to ensure form and function throughout product lifecycle.

The Personal Care portfolio of hair care products includes advanced styling polymers, fixatives, conditioning polymers, emulsifiers, preservatives, rheology modifiers and biofunctional actives.

The Personal Care portfolio of ingredients and solutions for skin care, sun care, and cosmetics focuses on natural and sustainable solutions. Personal Care includes biofunctional actives, preservatives, and specialty polymers to provide functionality such as water resistance and rheology. Ashland’s natural ingredients include a wide range of cellulose, guar, and cassia derivatives; unique active ingredients derived from botanical sources

5

using exclusive Ashland technologies such as Zeta FractionTM and plant small RNAs ("PSR") technology; emollients based on natural chemistries; encapsulation technology derived from alginates; and efficacious preservative blends inspired by nature.

The Personal Care portfolio of products and technologies is used in many types of cleaning and fragrance applications, including fabric care, home care and dishwashing. Personal Care products are used in a variety of applications for viscosity enhancement, particle suspension, rheology modification, stabilization and fragrance enhancement.

Personal Care operates throughout the Americas, Europe and Asia Pacific. It has 9 manufacturing facilities and laboratory facilities in 10 countries which serve its various end markets and participates in one joint venture. Its US facilities are located in Bridgewater Township, New Jersey; Freetown, Massachusetts and Kenedy, Texas; and internationally in Brazil; China; France; Germany; India; Mexico; Netherlands; Thailand; and the United Kingdom.

Personal Care markets and distributes its products in the Americas, Europe, the Middle East, Africa and Asia Pacific.

For the year ended September 30, 2026, the following Personal Care product categories were 10% or greater of Ashland’s total consolidated sales:

Product

% of Personal Care sales

% of Ashland total consolidated sales

Cellulosics

21%

40%

PVP

23%

24%

SPECIALTY ADDITIVES

Specialty Additives offers industry-leading products, technologies and resources for solving formulation and product-performance challenges. Using cellulosic based materials, synthetic and semisynthetic polymers derived from polyester and polyurethane-based chemistries, and other synthetic additives, Specialty Additives offers comprehensive and innovative solutions for industrial applications.

Key customers include manufacturers of paint, coatings and construction materials; packaging and converting companies; and oilfield service companies.

The areas of expertise include organic and synthetic chemistry, colloid science, rheology, structural analysis and microbiology.

The solutions provide an array of properties, including thickening and rheology control, binding power, film formation, conditioning and deposition, colloid stabilization and suspension.

Specialty Additives is composed of various end use markets. Many of the products of the end markets are produced in shared manufacturing facilities, to better manage capacity and achieve desired returns.

Specialty Additives provides products and services to over 30 industries. Ashland offers a broad spectrum of organo- and water-soluble polymers that are derived from both natural and synthetic resources. Product lines include derivatized cellulose polymers, synthetics, and vinyl pyrrolidone polymers that impart effective functionalities to serve a variety of industrial markets and specialized applications. Many of the products within

6

Specialty Additives function as performance additives that deliver high levels of end-user value in formulated products. In other areas, such as plastics and textiles, Specialty Additives’ products function as a processing aid, improving the quality of end products and reducing manufacturing costs.

Specialty Additives is a recognized leader in rheology solutions for waterborne architectural paint and coatings. Products include hydroxyethylcellulose ("HEC"), which provides thickening and application properties for interior and exterior paints, and nonionic synthetic associative thickeners ("NSATs"), which are APEO-free liquid synthetics for high-performance paint and industrial coatings. The Specialty Additives market complements its rheology offering with a broad portfolio of performance foam-control agents, surfactants and wetting agents, dispersants and pH neutralizers.

Specialty Additives is a major producer and supplier of cellulose ethers and companion products for the construction industry. These products control properties such as water retention, open time, workability, adhesion, stabilization, pumping, sag resistance, rheology, strength, appearance and performance in dry-mortar formulations.

Specialty Additives is a leading global manufacturer of synthetic- and cellulosic-based products for drilling fluids, oil-well cement slurries, completion and workover fluids, fracturing fluids and production chemicals. Specialty Additives offers the oil and gas industry solutions for drilling, stimulation, completion, cementing and production applications.

Specialty Additives operates throughout the Americas, Europe and Asia Pacific. It has 8 manufacturing facilities and laboratory facilities in 8 countries which serve its various end markets. Its US manufacturing facilities and laboratory facilities are located in Wilmington, Delaware and Hopewell, Virginia; and internationally in Brazil; China; France; Germany; India; Netherlands and the United Kingdom.

Specialty Additives markets and distributes its products in the Americas, Europe, the Middle East, Africa and Asia Pacific.

For the year ended September 30, 2026, the following Specialty Additives products were 10% or greater of Ashland’s total consolidated sales:

Product

% of Specialty Additives sales

% of Ashland total consolidated sales

Cellulosics

60%

40%

PVP

8%

24%

INTERMEDIATES

Intermediates is a leading producer of BDO and related derivatives, including n-methylpyrrolidone. These products are used as chemical intermediates in the production of engineering polymers and polyurethanes, and as specialty process solvents in a wide array of applications including electronics, agriculture, pharmaceuticals, water filtration membranes and more. BDO is also supplied to Life Sciences, Personal Care and Specialty Additives for use as a raw material.

7

Key customers include Ashland’s Life Sciences, Personal Care and Specialty Additives segments, general industrial manufacturers, plastics and polymers producers, pharmaceutical companies, agricultural firms and producers of electronic components and systems.

Intermediates has a manufacturing facility in Lima, Ohio, while some derivatives are produced at Life Sciences facilities in Texas City, Texas and Calvert City, Kentucky. Intermediates markets and distributes its products in the Americas, Europe, and Asia Pacific.

MISCELLANEOUS

Environmental Matters

Ashland maintains a company-wide environmental policy overseen by the Sustainability and Productivity Committee of Ashland’s Board of Directors (the "Board"). Ashland’s Environmental, Health, Safety, Quality and Regulatory Affairs ("EHSQ&RA") department has the responsibility to ensure that Ashland’s businesses worldwide maintain environmental compliance in accordance with applicable laws and regulations. This responsibility is carried out via training; widespread communication of EHSQ&RA policies; information and regulatory updates; formulation of relevant policies, procedures and work practices; design and implementation of EHSQ&RA management systems; internal auditing; monitoring of legislative and regulatory developments that may affect Ashland’s operations; assistance to the businesses in identifying compliance issues and opportunities for voluntary actions that go beyond compliance; and incident response planning and implementation.

Federal, state and local laws and regulations relating to the protection of the environment have a significant impact on how Ashland conducts its businesses. In addition, Ashland’s operations outside the United States are subject to the environmental laws of the countries in which they are located. These laws include regulation of air emissions and water discharges, waste handling, remediation and product inventory, registration and regulation. New laws and regulations may be enacted or adopted by various regulatory agencies globally. The costs of compliance with any new laws or regulations cannot be estimated until the manner in which they will be implemented has been more precisely defined.

At September 30, 2026, Ashland’s reserves for environmental remediation and related environmental litigation amounted to $222 million, reflecting Ashland’s estimates of the most likely costs that will be incurred over an extended period to remediate identified conditions for which the costs are reasonably estimable, without regard to any third-party recoveries. Engineering studies, historical experience and other factors are used to identify and evaluate remediation alternatives and their related costs in determining the estimated environmental remediation reserves. Environmental remediation reserves are subject to uncertainties that affect Ashland’s ability to estimate its share of the costs. Such uncertainties involve the nature and extent of contamination at each site and the extent of required cleanup efforts under existing environmental regulations. Although it is not possible to predict with certainty the ultimate costs of environmental remediation, Ashland currently estimates that the upper end of the reasonably possible range of future costs for identified sites could be as high as approximately $470 million. The largest environmental remediation reserve for any site is 22% of the total environmental remediation reserves. Ashland regularly adjusts its reserves as environmental remediation progress and litigation develops. Environmental remediation expense, net of estimated insurance

8

recoveries, amounted to $38 million, $48 million and $56 million for the years ended September 30, 2026, 2025 and 2024, respectively.

Product Control, Registration and Inventory - Many of Ashland’s products and operations are subject to chemical control laws of the countries in which they are located. These laws include regulation of chemical substances and inventories under the Toxic Substances Control Act ("TSCA") in the United States and the Registration, Evaluation and Authorization of Chemicals ("REACH") regulation in Europe as well as new cosmetic ingredients filings in China under the Cosmetics Supervision and Administration Regulation ("CSAR"). Under TSCA, REACH, and CSAR additional testing requirements, documentation, risk assessments and registrations are occurring and will continue to occur and may adversely affect Ashland’s costs of products produced in or imported into the European Union ("EU"). Examples of other product control regulations include right to know laws under the Global Harmonized System ("GHS") for hazard communication, regulation of chemicals used in the manufacture of pharmaceuticals and personal care products and that contact food under the Food, Drug and Cosmetics Act in the United States, the Framework Regulation in Europe and other product control requirements for chemical weapons, drug precursors and import/export. The Green Deal in the EU, specifically Chemicals Strategy for Sustainability, will require additional information to be developed on hazard communication and risk assessment of both chemical substances and finished products. New laws and regulations may be enacted or adopted by various regulatory agencies globally. The costs of compliance with any new laws or regulations cannot be estimated until the manner in which they will be implemented has been more precisely defined.

Remediation - Ashland currently operates, and in the past has operated, various facilities at which, during the normal course of business, releases of hazardous substances have occurred. Additionally, Ashland has known or alleged potential environmental liabilities at a number of third-party sites. Federal and state laws, including but not limited to the Resource Conservation and Recovery Act ("RCRA"), the Comprehensive Environmental Response, Compensation and Liability Act of 1980 ("CERCLA") and various other remediation laws, require that contamination caused by hazardous substance releases be assessed and, if necessary, remediated to meet applicable standards. Some of these laws also provide for liability for related damage to natural resources, and claims for alleged property and personal injury damage which can also arise related to contaminated sites. Laws in other jurisdictions in which Ashland operates require that contamination caused by such releases at these sites be assessed and, if necessary, remediated to meet applicable standards.

Air - In the United States, the Clean Air Act ("CAA") imposes stringent limits on facility air emissions, establishes a federally mandated operating permit program, allows for civil and criminal enforcement actions and sets limits on the volatile or toxic content of many types of industrial materials and consumer products. The CAA establishes national ambient air quality standards ("NAAQS") with attainment deadlines and control requirements based on the severity of air pollution in a given geographical area. Various state clean air acts implement, complement and, in many instances, add to the requirements of the federal CAA. The requirements of the CAA and its state counterparts have a significant impact on the daily operation of Ashland’s businesses and, in many cases, on product formulation and other long-term business decisions. Other countries where Ashland operates also have laws and regulations relating to air quality. Ashland maintains numerous permits and emission control devices pursuant to these clean air laws.

9

The United States Environmental Protection Agency ("USEPA") has increased its frequency in reviewing the NAAQS. The USEPA has stringent standards for particulate matter, ozone and sulfur dioxide. Throughout 2024, 2025 and 2026, state and local agencies continued to implement options for meeting the newest standards. Particulate matter strategies include dust control measures for construction sites and reductions in emission rates allowed for industrial operations. Options for ozone include emission controls for certain types of sources, reduced limits on the volatile organic compound content of industrial materials and consumer products, and requirements on the transportation sector. Most options for sulfur dioxide focus on coal and diesel fuel combustion sources. It is not possible at this time to estimate the potential financial impact that these newest standards may have on Ashland’s operations or products. Ashland will continue to monitor and evaluate these standards to meet these and all air quality requirements.

Solid Waste - Ashland is subject to various laws relating to and establishing standards for the management of hazardous and solid waste. In the United States, Ashland’s facilities are subject to RCRA and its regulations governing generators of hazardous waste. Ashland has implemented systems to oversee compliance with the RCRA regulations. In addition to regulating current waste disposal practices, RCRA also addresses the environmental effects of certain past waste disposal operations, the recycling of wastes and the storage of regulated substances in underground tanks. Ashland has the remediation liability for certain facilities subject to these regulations. Other countries where Ashland operates also have laws and regulations relating to hazardous and solid waste, and Ashland has systems in place to oversee compliance.

Water - Ashland maintains numerous discharge permits. In the United States, such permits may be required by the National Pollutant Discharge Elimination System of the Clean Water Act and similar state programs. Other countries have similar laws and regulations requiring permits and controls relating to water discharge.

Climate Change and Related Regulatory Developments - Ashland has been collecting energy use data and calculating greenhouse gas ("GHG") emissions for many years. Ashland evaluates the physical and transitional risks and opportunities from both climate change and the anticipated GHG regulations to facilities, products and other business interests, as well as the strategies commonly considered by the industrial sector to reduce the potential impact of these risks. These risks are generally grouped as impacts from legislative, regulatory and international developments, impacts from business and investment trends and impacts to Company assets from the physical effects of climate change. North American, European and other regional regulatory developments (most notably the European Union’s Corporate Sustainability Reporting Directive ("CSRD"), as amended, and the SEC’s climate disclosure rules, which never took effect and which the SEC has proposed to rescind) are monitored continuously for material impacts to Ashland’s operations, and some facilities and subsidiaries are subject to promulgated rules. Proposed and pending climate legislation is monitored for impact and Ashland is taking steps to strengthen climate reporting to meet anticipated disclosure requirements. Other requirements requiring additional product level climate disclosures or supply chain transparency are also approved and in draft or finalized status and could impact the requirements for disclosure and restrictions on sourcing of raw materials. Regulations such as the PFAS restrictions and microplastics ban in the EU have potential business interruption impacts where they limit the type and availability of raw materials that may be used.

10

Business and investment trends are expected to drive an increase in the demand for products that improve energy efficiency, reduce energy use and increase the use of renewable resources. At this time, Ashland cannot estimate the impact of this expected demand increase to its businesses. Physical effects from climate change have the potential to affect Ashland’s assets in areas prone to sea level rise or extreme weather events much as they do the general public and other businesses. Due to the uncertainty of these matters, Ashland cannot estimate the impact at this time of GHG-related developments on its operations or financial condition.

Competition

Ashland competes in the highly fragmented additives and specialty ingredients industries. The participants in these industries offer a varied and broad array of product lines designed to meet specific customer requirements. Participants compete with service and product offerings on a global, regional and/or local level subject to the nature of the businesses and products, as well as the end-markets and customers served. Competition is based on several key criteria, including product performance and quality, product price, product availability and security of supply, responsiveness of product development in cooperation with customers, customer service, industry knowledge and technical capability. Certain key competitors are significantly larger than Ashland and have greater financial resources, leading to greater operating and financial flexibility. The industry has become increasingly global as participants have focused on establishing and maintaining leadership positions outside of their home markets. Many of these segments’ product lines face domestic and international competition, due to industry consolidation, pricing pressures and competing technologies. Through a more focused approach, the Company is leveraging the Ashland brand and global scale to combine operational agility with disciplined investment in targeted areas, while expanding beyond its core technologies with differentiated new technology platforms to support the introduction of new product lines and applications.

Intellectual Property

Ashland has a broad intellectual property portfolio which is an important component of its business. Ashland relies on patents, trade secrets, formulae and know-how to protect and differentiate its products and technologies. In addition, the reportable segments own valuable trademarks which identify and differentiate their products from Ashland's competitors. Ashland also uses licensed intellectual property rights from third-parties.

Raw Materials and Energy

Ashland purchases its raw materials from multiple sources of supply in the United States and other countries. Raw material supplies were available in quantities sufficient to meet demand in fiscal 2026, 2025 and 2024. Similarly, energy costs, which are a significant component of production costs, were stable in fiscal 2026, 2025 and 2024.

11

Research and Development

Ashland’s program of research and development is focused on defining the needs of the marketplace and framing those needs into technology platforms. Ashland has the capability to develop and deliver the intellectual property required to grow and protect those platforms. Ashland is focused on developing new chemistries, market-changing technologies and customer driven solutions at numerous technology centers located in the Americas, Europe and the Asia Pacific regions.

Seasonality

Ashland’s business may vary due to seasonality. Ashland’s reportable segments typically experience stronger demand during warmer weather months.

Human Capital

Employee Health and Safety - Cultivating a safety culture is intentional at Ashland and is best shown by its commitment to a Zero Incident Culture ("ZIC"). ZIC begins with the vision, values, beliefs, and actions of Ashland’s leaders demonstrating that zero incidents is possible. It means developing processes where compliance is the minimum expectation, allowing employees to proactively manage safety above compliance on the journey to zero.

As an indication of its commitment to Responsible Care, Ashland obtained a third-party certification to RC14001, which includes the internationally recognized ISO 14001 certification and adds additional health, safety, security, and chemical industry requirements. Currently, Ashland has 21 sites participating on a group RC14001 certification, including 11 international sites. Also, as part of its commitment to health and safety, 19 of the Company's sites have obtained an additional ISO 45001 certification, an international health and safety management system.

As part of ZIC, the Company strives every day to achieve zero incidents. Ashland continues to make good progress on its journey. For the year ended September 30, 2026, the Company had an Employee Total Incident Recordable Rate ("TRIR") of 0.33 compared to 0.41 for the year ended September 30, 2025.

Ashland has implemented several tools for communicating lessons learned from injuries, process safety incidents, and environmental releases. Immediately following an event, flash reports are developed and shared to communicate key lessons learned across the Company within 48 hours with Ashland’s Environmental, Health and Safety (“EHS”) leadership team and Operations Leadership. Additionally, incidents and root causes/corrective and preventive actions are reviewed monthly with Company leadership and EHS leaders globally to discuss areas for improvement and highlight the importance of identifying and addressing management system errors.

Ashland has implemented the “Good Catch” Program aimed at identifying underlying unsafe conditions or behaviors that could lead to an undesirable outcome. Employees are encouraged to report good catches that fall into one of three categories – substandard conditions, near misses, and suggestions. These are tracked with the goal of continuing to increase overall reporting of identified good catches year to year.

Environmental – Ashland has a conscious and proactive mindset for sustainability. In February 2021, Ashland announced its intention to align its operations with the aim of the Paris Climate Accord to limit global

12

temperature rise to 1.5°C above preindustrial levels. At that time, Ashland also became a signatory to the United Nations Global Compact and is making the United Nations principles part of the Company's business strategy, culture, and day-to-day operations. Ashland’s previous targets to reduce its environmental footprint concluded in 2025 and Ashland is currently developing its next generation of environmental targets. In the interim, Ashland maintains a GHG emissions reduction target and continues to focus on reducing its overall environmental footprint. These targets and progress towards meeting them can be found on: https://www.ashland.com/esg/esg-overview, which is not incorporated by reference into the Annual Report on Form 10-K.

Ashland is committed to ensuring compliance with applicable environmental, health, safety and security laws, regulations, technical specifications, and internal standards, while adhering to high ethical standards. We are committed to continuously improving our processes and to providing products and services that throughout their life cycle involve minimum risk to people and the environment, while best meeting the needs of our customers. We strive to eliminate or reduce emissions, discharges, and wastes from our operations and to promote energy efficiency and resource conservation throughout the value chain.

Ashland also maintains an open dialogue with our employees and communities about environmental, health, safety, security, and product stewardship issues. We also work with governments, policy makers, advocacy groups and value chain partners to develop and promote laws, regulations and practices that improve human health and the environment.

Human Capital Management – Ashland’s people are the foundation of its innovation, performance, and long-term success. The Company is committed to cultivating a growth-minded, high-integrity culture that empowers employees to thrive, contribute meaningfully, and lead with purpose. Ashland’s human capital strategy is designed to attract, develop, and retain exceptional global talent while fostering a workplace where everyone feels they belong and are inspired to excel.

As of September 30, 2026, Ashland had approximately 2,800 employees in 31 countries. The Company’s workforce reflects a broad range of experiences and perspectives, united by a shared commitment to solving complex challenges for customers.

Culture and Values – Ashland fosters a workplace environment that is rooted in respect, integrity, and opportunity. All programs and practices are conducted in accordance with applicable nondiscrimination laws and are designed to support equitable access and merit-based advancement for all employees.

Ashland believes that inclusion is essential to innovation and performance. In 2026, the Company advanced its global talent strategy with a focus on accountability, change, innovation, and care. These efforts are designed to create a collaborative environment that leverages the talents of a diverse global workforce and supports sustainable growth.

Ashland’s focus on advancing its culture starts at the top. The Board is composed of individuals with diverse experience and credentials, selected for their business acumen, deep expertise and insight, and ability to

13

challenge and add value to the management team. Both the Board of Directors and Executive Committee are engaged in shaping a culture that amplifies the Company values: we care, we commit, we solve together.

The Company also recognizes and celebrates employees who exemplify its values through programs such as the Ashland Way Awards and Responsible Solvers™. As part of its commitment to community engagement and global citizenship, Ashland encourages employee participation in the Responsible Solvers™ program. This initiative combines the Company’s philanthropic focus on STEM education with volunteer opportunities, empowering employees to make a meaningful impact in the communities where they live and work. Eligible employees may receive up to 16 hours of paid time-off annually to engage in manager-approved volunteer activities during regular work hours.

Talent Development and Leadership – Ashland is building a people ecosystem that enables personal and professional growth at every level. The Company conducts disciplined annual talent reviews and succession planning to strengthen its leadership pipeline, promote internal mobility, and minimize attrition. The performance management process provides employees with ongoing feedback not only on performance, but also on their developmental progress and how they live the Ashland values.

In 2026, Ashland advanced the capabilities of its leaders through global leadership development, financial acumen, and sales training programs, along with additional continuous learning opportunities that were delivered both in-person and on-demand. Ashland also provided tuition assistance for undergraduate, graduate, and PhD programs, as well as technical and professional development opportunities.

Well-being and Engagement – Ashland continues to focus on employee wellness and executing the global vision to empower employees and their families to make healthy decisions that lead to positive outcomes in and outside of work. The Company’s well-being initiatives focus on four pillars: health, work-life balance, physical fitness, and financial stability. To that end, Ashland offers its employees wellness programs and events, including global Employee Assistance Programs, preventative care resources, and flexible leave benefits. In 2026, Ashland emphasized financial well-being through a series of impactful webinars delivered in partnership with Fidelity.

The Company also conducts its annual global Culture Survey to measure engagement, and gain valuable insights which guide our investments in tools, resources, and practices that will enhance both employee and organizational productivity, effectiveness, and commitment.

Ethical Standards and Human Rights – Ashland is committed to respecting the human and economic rights of others and does not tolerate the use of child or forced labor, slavery, or human trafficking in any of its facilities or operations. Ashland does not tolerate the physical punishment, abuse, involuntary servitude or exploitation of any worker and we expect our suppliers and contractors with whom we do business to uphold the same

14

standards and will discontinue the business relationship with any individual or company that does not follow the same standards.

Ashland's global footprint is geographically located as follows:

Competitive Pay and Benefits – Ashland is committed to paying its employees in a fair and equitable manner and has implemented global total rewards tools to promote equitable remuneration. The Company provides a total compensation package that is designed to be competitive with the markets in which it competes for talent. Ashland believes employees should be compensated equitably based on performance, skills, and experience.

Ashland reviews pay equity annually in conjunction with its annual performance review, merit, bonus and promotion processes. The Company annually completes an in-depth analysis of its pay equity globally using a number of factors to determine if a pay gap exists. Overall findings continue to be encouraging, identifying only a few employees annually that had a disparity in pay requiring further analysis and corrective action. Ashland reviews each process annually to ensure that its policies, procedures, and training continue to provide pay equity within the Company.

Since 2024, Ashland has been certified as a Global Living Wage Employer by the Fair Wage Network, an independent organization that evaluates compensation against locally established living wage standards. A living wage is intended to provide sufficient income to meet the basic needs of employees and their dependents for housing, food, water, healthcare, transportation, clothing and education and is distinct from statutory minimum wage or competitive requirements. Ashland maintains this certification bi-annually through a re-certification process reflecting its ongoing commitment to equitable and competitive compensation practices.

The Company’s compensation programs are globally aligned, and, where possible, its total rewards plans include base salary, short- and long-term incentives, benefits, financial, and special recognition programs. The

15

Company routinely reviews its total rewards practices in the markets in which it operates to ensure its plans allow for both the recruitment and retention of the talent it needs to be successful while also providing for a living wage in every location.

Ashland also offers a competitive global benefits program to support employees through all life stages. The following benefit plans are available to employees depending on local markets in which the Company operates that include plan-specific features such as on-site and on-demand resources:

•
Health care benefits including medical, prescription, dental and/or vision

•
Wellness initiatives:

o
Global EAP (employee assistance program)

o
Flu vaccination resources

•
Paid time off

•
Voluntary benefits

•
Life and accident coverage

•
Disability coverage

•
Retirement plans

•
Tuition reimbursement

•
Business travel accident

Forward-Looking Statements

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements are not historical facts and generally are identified by words such as “anticipates,” “believes,” “estimates,” “expects,” “is likely,” “predicts,” “projects,” “forecasts,” “objectives,” “may,” “will,” “should,” “plans,” and “intends” and the negative of these words or other comparable terminology. Although Ashland believes that its expectations are based on reasonable assumptions, such expectations are subject to risks and uncertainties that are difficult to predict and may be beyond Ashland’s control. As a result, Ashland cannot assure that the expectations contained in such statements will be achieved. Important factors that could cause actual results to differ materially from those contained in such statements are discussed under “Use of estimates, risks and uncertainties” in Note A of Notes to Consolidated Financial Statements in this Annual Report on Form 10-K. For a discussion of other factors and risks that could affect Ashland’s expectations and operations, see “Item 1A. Risk Factors” in this Annual Report on Form 10-K.